IRhythm Argues Patent Owner's Inaction Shouldn't Doom IPRs

A heart monitoring company told the acting U.S. Patent and Trademark Office director that it shouldn't be barred from challenging a patent just because the company had known about it for...

Already a subscriber? Click here to view full article